Arash Rassoulpour, PhD

Arash Rassoulpour serves as Chief Operating Officer. In this role he is responsible for multiple aspects of the business and has contributed to the company’s expansion and to the growth of the pipeline. Arash is an experienced drug developer and operational leader with over 15 year’s industry experience. Prior to Neuron23 he served as Executive Director and General Manager at Charles River Laboratories (CRL) where he served as the South San Francisco Site Head, and served as a member of the Discovery leadership team.

Before becoming part of CRL Arash served as Head of US operations/Partner of Brains On-Line where he was responsible for the expansion and eventual acquisition by CRL. Arash started his industry career as Senior Scientist in Neuroscience group at Amgen where led several neuroscience programs in psychiatry including a program that eventually entered clinical trials. Arash holds a PhD in Neuroscience from the University of Maryland.